Clomipramine-d6 Hydrochloride
Product Code
TRC-C587052
CAS Number
Product Format
Neat
Molecular Formula
C19H17D6ClN2 • HCl
Molecular Weight
320.893646
API Family
Clomipramine HydrochlorideProduct Categories
Antidepressants, Antidepressants, TRC, API Reference Standards & Research Materials, Antidepressants, 5-HT receptors, Neurotransmission, Nociception, Alzheimer's, Memory, Learning and Cognition, Parkinson's, Addiction, Schizophrenia, Pain and Inflammation, Stable isotopes, Stable Isotope Labelled Analytical Standards
Unlabelled CAS Number
Purity
>95% (HPLC)
Drug Type
Antidepressants
Documentation
Looking for another lot?
To view all certificates of analysis immediately, please login to your account
or
{{ errors.first('lotNumber') }}
{{ errors.first('requestEmail') }}
For information about our data processing activities, please visit our Privacy Notice.
Enter your email address and we'll email you the relevant CoA for lots:
{{ coaPopupData.packSize.coaSelectedLotNumbers }}
{{ errors.first('coaEmail') }}
We will be sending the CoA to your email address {{ coaEmailPopupData.userEmail }}
Your request has been sent to our sales team to process.
Find an SDS for your region
{{ errors.first('selectedRegion') }}
{{ errors.first('sdsEmail') }}
For information about our data processing activities, please visit our Privacy Notice.
Your request has been sent to our sales team to process.
Product Information
Chemical Data
Analyte Name
Clomipramine-d6 Hydrochloride
CAS Number
1189882-28-7
Molecular Formula
C19H17D6ClN2 • HCl
Molecular Weight
320.893646
SMILES
[2H]C([2H])([2H])N(CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl)C([2H])([2H])[2H].Cl
Unlabelled CAS Number
17321-77-6
SIL Type
Deuterium
Product Data
Storage Temperature
-20°C
Shipping Temperature
Room Temperature
Country of Origin
CANADA
Product Type
API; Stable Isotope Labelled
Product Format
Neat
API Family
Purity
>95% (HPLC)
Product Description
Serotonin reuptake inhibitor. Antidepressant
References: Peters, M.D., et al.: Clin. Pharm., 9, 165 (1990), Adamczyk, M., et al.: Ther. Drug Monit., 17, 371